Teva Pharmaceutical Industries Limited at Morgan Stanley Global Healthcare Conference Transcript
So before we get started, please note that this presentation is for Morgan Stanley institutional clients and employees. For all important disclosures, please see the Morgan Stanley Research Disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your MS sales rep, and I apologize for how many times I am going to say that over the next three days.
Questions & Answers
So perhaps we get started. Richard, before we go into detail, perhaps you could start with introductory comments as to where we are in the Teva story today, progress on the Pivot to Growth strategy, and the outlook from here.
Okay. I will try and be brief because obviously I could spend the whole time talking about that. Where we are in the story, to answer that first
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
